PODD Stock Price, News and Analysis
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Market Cap: $11,171,006,622.72
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Track PODD stock with real-time alerts and market analysis
Current Price: $161.28
Insulet Corporation
$161.28
+1.20%+$1.92
Major market announcement affects tech stocks across all sectors
Earnings report shows significant growth in quarterly revenue
Regulatory changes impact industry outlook for upcoming quarter